We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DLG:MILDe'Longhi S.p.A. Analysis

Data as of 2026-06-07 - not real-time

€35.50

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

De'Longhi is trading just above its short‑term moving average and remains close to a well‑defined support zone, while the 20‑day SMA sits near the 50‑day SMA, suggesting a neutral price stance. Momentum indicators show a mid‑range RSI and a bearish MACD crossover, hinting at limited upside in the immediate term. Volume has been on a downward trend, reinforcing the neutral technical outlook, and the 30‑day volatility remains elevated, reflecting a fairly choppy market environment. On the fundamentals side, the company delivers modest revenue growth, healthy gross and operating margins, and a solid return on equity above 15%, underpinning its earnings resilience. The dividend yield near 2.4% is supported by a low payout ratio and strong cash flow generation, indicating sustainability. A DCF‑derived fair value around €43 provides a clear upside buffer of roughly 20% versus the current price, aligning with the strong‑buy consensus from analysts. Combined with a low debt profile and a diversified geographic footprint, the stock presents a compelling case for patient investors.
From a risk perspective, the sector’s cyclical nature and the company’s exposure to multiple regions introduce medium‑level geographic and currency considerations, yet the low beta and limited regulatory headwinds keep overall risk moderate. The liquidity profile is solid given the market cap and average trading volumes, despite a recent dip in daily activity. With the dividend’s durability, attractive valuation gap, and robust fundamentals, the recommendation leans toward buying for the medium and long horizons while adopting a cautious hold stance in the very short term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • price near technical support
  • bearish MACD crossover
  • elevated short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • valuation gap to DCF fair value
  • sustainable dividend yield
  • strong earnings margins and cash flow

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • low leverage and solid balance sheet
  • global brand diversification
  • consistent dividend policy with growth upside

Key Metrics & Analysis

Financial Health

Revenue Growth3.00%
Profit Margin8.42%
P/E Ratio16.6
ROE15.31%
ROA7.17%
Debt/Equity23.01
P/B Ratio2.6
Op. Cash Flow€583.9M
Free Cash Flow€399.3M

Technical Analysis

TrendNeutral
RSI54.3
Support€33.62
Resistance€37.20
MA 20€35.44
MA 50€33.94
MA 200€34.02
MACDBearish
VolumeDecreasing
Fear & Greed Index83.02

Valuation

Fair Value€42.98
Target Price€43.21
Upside/Downside21.72%
GradeUndervalued
TypeBlend
Dividend Yield2.39%

Risk Assessment

Beta0.24
Volatility34.51%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.